Ligand Pharmaceuticals (LGND) Minority Interest (2010 - 2015)

Ligand Pharmaceuticals has disclosed Minority Interest across 4 years of filings, most recently posting -$2.8 million for Q1 2015.

• Minority Interest for Q1 2015 came in at -$2.8 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2015 was -$2.8 million (changed N/A YoY), and the FY2014 annual result was -$1.9 million, changed N/A from the prior year.
• Minority Interest came in at -$2.8 million for Q1 2015 at Ligand Pharmaceuticals, down from -$1.9 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $8.3 million in Q2 2011 to a low of -$2.8 million in Q1 2015.
• The 3-year median for Minority Interest is -$1.1 million (2014), against an average of $2.5 million.
• Peak annual rise in Minority Interest reached 0.0% in 2011, while the deepest fall reached 0.0% in 2011.
• Ligand Pharmaceuticals' Minority Interest stood at $8.3 million in 2011, then sank by 122.89% to -$1.9 million in 2014, then slumped by 44.14% to -$2.8 million in 2015.
• The last three Minority Interest figures came in at -$2.8 million (Q1 2015), -$1.9 million (Q4 2014), and -$1.6 million (Q3 2014), per Business Quant data.